Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis

Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis

In recent years, nerve growth factor (NGF) and the NGF receptor have become potential therapeutic targets in the treatment of acute and chronic pain states. NGF is a neurotrophin involved in regulating the function of sensory and sympathetic neurons during development. Numerous pain states have been...

Full description

Bibliographic Details
Main Authors: Mona K Patel, Alan D Kaye, Richard D Urman
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Journal of Anaesthesiology Clinical Pharmacology
Subjects:
Monoclonal antibody
nerve growth factor
neuropathic pain
tanezumab
tropomyosin-related kinase
Online Access:http://www.joacp.org/article.asp?issn=0970-9185;year=2018;volume=34;issue=1;spage=111;epage=116;aulast=Patel

Internet

http://www.joacp.org/article.asp?issn=0970-9185;year=2018;volume=34;issue=1;spage=111;epage=116;aulast=Patel

Similar Items